Abiopharma

New Form 424B5 - Pluri Inc. <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001213900-26-094704 <b>Size:</b> 367 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025223 <b>Size:</b> 698 KB

New Form SCHEDULE 13D/A - Evogene Ltd. <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001213900-26-094703 <b>Size:</b> 20 KB

New Form 424B3 - RedCloud Holdings plc <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001493152-26-040523 <b>Size:</b> 74 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001140361-26-034787 <b>Size:</b> 316 KB

Financial Statements and Related Announcement: Full Yearly Results

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013046 <b>Size:</b> 244 KB

Annual Reports and Related Documents:

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025222 <b>Size:</b> 1 MB

Teva Pharmaceutical Industries Ltd. -Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025221 <b>Size:</b> 932 KB

New Form 424B3 - RedCloud Holdings plc <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001493152-26-040520 <b>Size:</b> 75 KB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/Changes in Interest of Substantial Shareholder

General Announcement: TMG - FY2026 Results Briefing

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy